This case study looks at the role of intellectual property rights in the benefit-sharing arrangements concerning the “Jeevani” drug, which was developed by scientists at the Tropical Botanic Garden and Research Institute (TBGRI), based on the tribal medicinal knowledge of the Kani tribe in Kerala, South India.
